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Abstract
Background: Self-report in people with age-related macular degeneration (AMD) shows that they lead less active
lifestyles. Physical activity is important as it has been shown to improve quality of life, reduce co-morbidity and also
slow down the progression of AMD. Self-reported measures of physical activity are prone to subjective biases and
therefore less accurate in quantifying physical activity. This study compared self-reported and objective (accelerometer-
based) physical activity levels and patterns in older adults with AMD.
Methods: Data were collected in 11 AMD subjects with binocular vision loss (aged 76 ± 7 years), 10 AMD subjects with
good binocular vision (aged 76 ± 7 years), and 11 controls (aged 70 ± 4 years). Binocular vision was established using
visual acuity score. Contrast sensitivity and visual fields were also measured. Self-reported sedentary behaviour and
moderate-to-vigorous physical activity (MVPA) was assessed using the Global Physical Activity Questionnaire. Objective
measurements were obtained with an Actigraph GT3X accelerometer being worn for seven consecutive days on the
hip. The objective physical activity measures were sedentary behaviour, light physical activity, MVPA, and step count.
Results: Objectively measured MVPA was 33–34% higher for controls compared to both AMD groups (p < 0.05). There
were no group differences for any of the other objectively measured physical activity variables and self-reported
physical activity variables were also not significantly different (all p > 0.05). Comparing the objective with the self-report
physical activity measure showed that all groups under-reported their sedentary behaviour and MVPA, but controls
under-reported their MVPA more than both AMD groups (p < 0.05). Weak to moderate correlations were observed
between the severity of vision loss and objective physical activity measures (all − 0.413≥ r≤ 0.443), while correlations
for self-reported physical activity measures were less strong (all − 0.303≥ r≤ 0.114).
Conclusions: People with AMD, irrespective of whether they were vision impaired, were better able to estimate the
time spent in MVPA compared to controls. However, objectively measured MVPA, was higher in controls than AMD
subjects. Although clinicians may use self-report to monitor the compliance of AMD subjects with any prescribed
exercise programs, they should be aware that a valid comparison with healthy controls can only be made when MVPA
is objectively measured.
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Background
Physical activity is defined as any bodily movement
produced by skeletal muscles that results in energy ex-
penditure [1]. Individuals with vision loss (defined as
partial sight or blindness in the better seeing eye) experi-
ence various barriers to being physically active [2]. This
is of concern as the latest reports from 2010 on global
vision loss show that 32 million people were blind and
191 million people had moderate and severe vision im-
pairment [3, 4]. This number is set to double by 2050
because of the ageing population [5]. Age-related macu-
lar degeneration (AMD) leads to irreversible loss of
central vision and is the second most common cause of
blindness and the third main cause of partial sight in
high-income countries [6]. The disease mainly affects
people aged 50 years and over [7, 8]. The loss of central
vision in late AMD results in mobility limitations that
make the performance of everyday tasks more difficult [9].
These limitations result in less active lifestyles compared
to older adults with normal vision (i.e., increased seden-
tary time, lower daily step count, and less time spent in
moderate-to-vigorous physical activity [MVPA]) [10, 11].
It is important to encourage physical activity because
it has been shown to improve quality of life and reduce
co-morbidity [12]. In addition, a recent meta-analysis
(nine studies from Europe, Australia, and USA; n = 66,
966) showed that low levels of physical activity were as-
sociated with 8 and 41% higher odds of early and late
AMD respectively [13]. The authors of this meta-
analysis [13] recommended also that a more precise
quantification of physical activity in people with AMD is
necessary using objective as opposed to self-reported
measures. Although self-reported measures have a prac-
tical value in monitoring changes in physical activity
over time, and in detecting health benefits for large clin-
ical populations, they are more prone to subjective bias
and therefore less accurate in quantifying physical activ-
ity [14]. To illustrate, self-reported MVPA in prostate
cancer survivors has been found to be greatly overesti-
mated [15], and sedentary time was underestimated by
396 min/day in a population of healthy adults [16].
There are several reasons why self-reported and ob-
jective measures of physical activity do not correspond.
Self-reported measures have been shown to be less ac-
curate in quantifying light-intensity physical activity
(e.g., household chores), they are cognitively demanding
and are susceptible to recall biases, psychosocial factors
such as anxiety, and social desirability of needing to re-
port particular behaviours [14]. It is therefore likely that
these biases also exist in individuals with AMD. For ex-
ample, people with AMD are more likely to have cogni-
tive impairments [17–20] that may affect their cognitive
processing of the questions, and accurate recalling of
physical activity. The severity of vision loss might also
affect self-reported physical activity as AMD subjects with
early AMD (good vision) might not feel inclined to report
socially desirable behaviour compared to those with late
AMD (impaired vision). However, no studies to date have
examined how self-reported and objectively measured
physical activity compare in individuals with AMD.
The present study compares self-reported and object-
ive (accelerometer-based) physical activity levels in
AMD subjects with binocular vision loss, AMD subjects
with good binocular vision, and older adults with normal
vision. It is expected that older adults with normal vision
will be more physically active than AMD subjects with-
out vision loss, with AMD subjects with vision loss being
the least physically active. These group-differences will
become more pronounced when objectively measured.
Methods
Participants
Twenty-three individuals with AMD and 13 older adults
with normal or corrected-to-normal vision were re-
cruited to take part in the study. The AMD subjects
were divided in a group with vision loss (binocular visual
acuity > 0.3 logMAR [21], n = 12) and good binocular vi-
sion (visual acuity ≤0.3 logMAR [21], n = 11). All AMD
subjects were diagnosed with AMD (both eyes) by an
ophthalmologist. Recruitment of people with AMD took
place at local support group meetings and via letters that
were sent out by the Macular Society. An age-matched
sample of older adults with normal vision was recruited
via online advertisements and word of mouth. Inclusion
criteria for all subjects were: age ≥ 65 years, live inde-
pendently (non-institutionalized), and able to walk 100
m without severe physical restrictions. Exclusion criteria
were: cognitive impairment, severe neurological or mus-
culoskeletal problems, and eye disorders or ocular path-
ology affecting eye sight (except AMD). The health of all
subjects was assessed through a self-report questionnaire
and cognitive function was examined using the Mini
Mental State Examination (MSSE). Subjects were con-
sidered cognitively impaired when they scored below the
required score to pass the MMSE [22]. The last three
items of the MMSE require vision but AMD subjects in
the present study were able to perform on these items,
although some needed help with low vision aids such as
a magnifying glass.
All subjects provided written informed consent prior
to commencing the study. The study was approved by
the Research Ethics Committee of the Anglia Ruskin
University (approval number: FMSFREP 16/17008) and
is in accordance with the Declaration of Helsinki.
Study design
Data were collected in a specific time of the year (spring
and summer 2018) to minimise the effects of weather
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and daylight duration on the physical activity patterns
between subjects. Subjects visited the laboratory once to
do the visual examination, respond to questions of the
Global Physical Activity Questionnaire (GPAQ) in a
face-to-face interview [23] and receive instructions on
the use of the Actigraph GT3X accelerometer (Actigraph
Inc., Florida, USA). The questions in the GPAQ were re-
lated to a typical week and therefore all subjects were re-
quested to wear the Actigraph GT3X accelerometer
during the whole week. All subject started wearing the
Actigraph GT3X accelerometer in the first week after
the lab visit, and they wore it for seven consecutive days.
Once they completed the seven-day wearing period, they
returned the Actigraph GT3X accelerometer in person
or via mail.
Visual examination
The visual examination consisted of three tests that were
performed with best-corrected spectacles and always in
the same order. First, visual acuity was measured binocu-
larly using the Bailey-Lovie logMAR chart at a working dis-
tance of 4m using a letter-by-letter scoring system (0.02
logMAR) [24]. Shorter distances were used when a subject
was not able to read the largest size letters at 4m distance
and scores were adjusted accordingly. Second, contrast sen-
sitivity was assessed binocularly using the Pelli-Robson
chart at 1m distance, and scored per group of three letters
(0.15 log units) of which two had to be correct [25]. Lastly,
visual field examination was conducted monocularly using
a Humphrey Field Analyzer (Carl Zeiss Meditec Inc.,
Dublin, CA) SITA-Standard 30–2 threshold test. The mon-
ocular scores were then used to calculate the binocular vis-
ual fields using the “best location” model [26].
Objective assessment of physical activity
Subjects wore the Actigraph GT3X tri-axial accelerom-
eter for seven consecutive days on the right hip. The
Actigraph GT3X is an accurate [27] and reliable [28] ac-
celerometer for assessing free-living physical activity.
The Actigraph was attached to an elastic belt that was
worn around the subject’s waist near the iliac crest. Sub-
jects were instructed to wear the Actigraph during all
activities except water-based activities (such as bathing)
and when sleeping. The Actigraph measured the fre-
quency, intensity, and duration of physical activity by
generating an activity count proportional to the mea-
sured acceleration. The time spent at different physical
activity intensities was measured over 1-min epochs.
The amount of physical activity was expressed as time
(min/day) and was classified using the intensity thresh-
old values developed for older adults [29, 30]: sedentary
behaviour (0–99 cpm), light-intensity physical activity
(100–1040 cpm), and moderate- and vigorous-intensity
physical activity (MVPA) (≥ 1041 cpm). Step counts
were also recorded by the Actigraph GT3X accelerom-
eter and expressed in steps/day. Subjects needed to have
worn the Actigraph GT3X for at least four or more valid
days (wear time ≥ 600min/day) to be included in the
analysis. Non-wear time was determined using the cri-
teria defined by Choi et al. [31]. Actigraph data were
processed using ActiLife version 6.13.3.
Subjects also filled in an activity monitor log on the
days that they were wearing the Actigraph. The typog-
raphy of the log book was adjusted for people with
AMD to increase readability [32]. All subjects were able
to read and write in the log book. The activity monitor
log served as verification of when and why subjects were
not wearing the Actigraph. The Actigraph data matched
with the log in all participants.
Subjective assessment of physical activity
Subjective physical activity levels were assessed in a face-
to-face interview using the GPAQ [23]. The GPAQ is
developed by the World Health Organisation and con-
sists of 16 questions that examine sedentary behaviour
and level of physical activity during work, transport, and
leisure time. The GPAQ is a suitable surveillance instru-
ment to monitor physical activity in young and older
adults [33, 34]. The level of physical activity is defined as
the time spent doing moderate-intensity activities and
vigorous-intensity activities. The time spent in moderate-
intensity and vigorous intensity were combined and
defined as the time spent in MVPA. The experimenter
administered the questionnaire and recorded the re-
sponses. Data were analysed according to the WHO Steps
programme and expressed in min/day [23].
Subjects were also questioned on what types of phys-
ical activities they performed during a typical week.
These were extracted from the activity scale of the Allied
Dunbar Fitness Survey [35] and activities included walk-
ing, jogging, swimming, cycling, gardening, stationary
biking, tennis, and other aerobic exercises.
Data analysis
Data in text and figures are expressed as mean ± SD. The
statistical analysis was performed using SPSS version 24.
Normality was examined using the Kolmogorov-Smirnov
test. Each variable was normally distributed. Demographic
data were subjected to a univariate analysis of variance
(ANOVA) to determine between-group differences. Chi-
square test was used to determine between-group differ-
ences in gender. Data about the types of exercise were
summarized using descriptive statistics. A multivariate
ANOVA (MANOVA) was performed to test between-
group differences in objective physical activity scores,
subjective physical activity scores, and bias scores (i.e., dif-
ference score between the objective and subjective phys-
ical activity measure). Pillai’s Trace was used to determine
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between-group effects. A significant MANOVA was
followed up by univariate ANOVAs. The variables total
wear time, number of valid wear days, and step count
were analysed using univariate ANOVA. Bland-Altman
analysis [36] were performed to assess the agreement be-
tween objective and subjective measures of physical activ-
ity for both sedentary behaviour and MVPA. Significant F
values from the univariate ANOVA’s were subjected to an
LSD post hoc pairwise comparison to determine the
group means that were different. Pearson’s correlation co-
efficients were calculated to assess whether there is a rela-
tionship between the severity of vision loss and outcomes
of the Actigraph and GPAQ. The level of significance (α)
was set at p < 0.05. Effect sizes were calculated using
Cohen’s d.
A priory power analysis with G*Power 3.1 was per-
formed to calculate the required sample size to obtain a
significant group effect on the MANOVA for bias scores.
The effect of AMD on the bias scores has not been ex-
amined before. Therefore, a small effect size of 0.20 was
used for the power analysis to prevent underestimation
of the sample size. The calculated sample size was 11
subjects per group based on an effect size of 0.2 with a
power of 80% at the p < 0.05 significance level.
Results
Subject characteristics
The subject characteristics can be found in Table 1. One
AMD subject with binocular vision loss and one AMD
subject with good binocular vision were excluded from
the analysis because of technical issues with the Acti-
graph. Two controls with normal vision were also ex-
cluded from the analysis because they did not wear the
Actigraph for at least three days. Thus, the analysis was
performed on data from 11 AMD subjects with vision
loss, 10 AMD subjects without vision loss, and 11 con-
trols with normal vision.
Objective assessment of physical activity
Table 2 shows the data collected with the Actigraph.
The univariate ANOVAs revealed that the total wear
time, number of valid wear days, and step count were
not significantly different between groups (all p ≥ 0.173).
The MANOVA for the objective physical activity scores
showed a significant group effect (p = 0.023). Follow-up
with univariate ANOVAs showed that there were no sig-
nificant group differences for sedentary behaviour and
light-intensity physical activity (both p ≥ 0.103), but there
was a significant between-group difference for MVPA
(p = 0.011). Post hoc analysis revealed significant differ-
ences between AMD subjects and controls, in that both
AMD groups spent 33–34% less time in MVPA com-
pared to the control group (both p ≤ 0.011, d ≥ 1.05).
Subjective assessment of physical activity
The data of the GPAQ can be found in Table 2. The
MANOVA for subjective physical activity scores re-
vealed a non-significant group effect (p = 0.114).
Figure 1 shows the reported exercise types that sub-
jects engaged in. Walking and gardening are the most
popular forms of exercise among older adults, irrespect-
ive of whether they are diagnosed with AMD or not.
Cycling seems to be less popular among AMD subjects
with vision loss (9%) compared to AMD subjects with-
out vision loss (40%) and age-matched controls with
normal vision (45%).
Objective vs. subjective physical activity measures
Figure 2A-C demonstrate the results of the Bland-
Altman analysis per group for sedentary behaviour. All
three groups under-reported their sedentary behaviour
compared to the objective measure.
Figure 2E-G illustrate the results of the Bland-Altman
analysis per group for MVPA. All three groups under-
Table 1 Baseline characteristics of the participants (mean ± SD)
AMD subjects with vision loss
(n = 11)
AMD subjects without vision loss
(n = 10)
Controls with normal vision
(n = 11)
Age (years) 76 (7) 76 (7) 70 (4)
Gender (count)
Male 5 6 5
Female 6 4 6
Mass (kg) 72 (11) 74 (16) 69 (11)
Height (cm) 166 (9) 173 (10) 167 (6)
Visual acuity (logMAR)* 0.73 (0.20) 0.05 (0.12) 0.00 (0.10)
Contrast sensitivity (logCS)*† 0.74 (0.32) 1.37 (0.22) 1.69 (0.07)
Visual fields (dB)* 23 (5) 28 (2) 31 (1)
Mini-Mental State Examination score* 29 (1) 29 (1) 30 (1)
* Significant group difference between AMD subject with vision loss and the other two groups (p < 0.05); † Significant group difference between the AMD
subjects without vision loss and controls with normal vision (p < 0.05)
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Table 2 Physical activity data measured objectively using the GT3X Actigraph and subjectively using the Global Physical Activity
Questionnaire (GPAQ) (mean ± SD)
Variables AMD subjects with vision loss
(n = 11)
AMD subjects without vision loss
(n = 10)
Controls with
normal vision
(n = 11)
ANOVA
p-value
Actigraph
Total wear time (min/day) 838 (75) 873 (61) 880 (62) 0.298
Number of valid wear days 6.9 (0.3) 6.8 (0.4) 6.9 (0.3) 0.710
Sedentary behaviour (min/day) 462 (64) 443 (52) 424 (94) 0.482
Light-intensity activity (min/day) 224 (73) 285 (81) 241 (32) 0.103
MVPA (min/day) 143 (40)* 145 (36)* 216 (87) 0.011
Step count (steps/day) 6218 (3159) 5199 (2529) 8258 (4931) 0.173
GPAQ
Sedentary behaviour (min/day) 234 (113) 323 (126) 264 (102) N/A
MVPA (min/day) 102 (78) 127 (92) 92 (50) N/A
Bias1 Actigraph vs. GPAQ
Sedentary behaviour (min/day) 228 (118) 119 (106) 160 (132) 0.127
MVPA (min/day) 40 (93)* 18 (117)* 124 (86) 0.048
MVPA, moderate-to-vigorous physical activity; N/A, not applicable; 1, difference score between the objective and subjective measure of physical activity; *,
significantly different from controls with normal vision (p < 0.05)
Fig. 1 Overview of the exercise types per group. The frequency per group is reported between brackets
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reported their MVPA compared to the objective
measure.
The MANOVA for bias scores showed a group effect
(p = 0.003). Follow-up of univariate ANOVAs revealed a
non-significant group difference for the bias score in sed-
entary behaviour (p = 0.127, Fig. 2D and Table 2) but a
significant group difference for the bias score in MVPA
(p = 0.048, Fig. 2H and Table 2). Post hoc analysis revealed
that compared to controls with normal vision, the bias
was 68% less for AMD subjects with binocular vision loss
(p = 0.058, d = 0.94) and 85% less for AMD subjects with
good binocular vision (p = 0.021, d = 1.04).
Associations between the severity of vision loss and
physical activity
Table 3 shows that significant associations were found
between the amount of vision loss and objectively mea-
sured physical activity. Figure 3 illustrates the correla-
tions between visual acuity and the objective physical
activity measures. The strength of the significant associa-
tions was weak to moderate. No significant associations
were found between any of the vision parameters and
step count (r ≤ 0.162, p ≥ 0.188).
Table 3 also shows the associations between the amount
of vision loss and self-reported physical activity. No sig-
nificant associations were found except the moderate and
significant association between visual acuity and sedentary
behaviour. Figure 4 illustrates the correlations between
visual acuity and the physical activity parameters of the
GPAQ.
Discussion
The present study is the first to compare self-reported
with objective physical activity levels in individuals with
AMD. Individuals with AMD, irrespective of whether
they were vision impaired, were better able to estimate
their MVPA compared to controls. This is in contrast
with the hypothesis that the agreement between self-
reported and objectively measured MVPA would be less
for people with AMD compared to controls. A possible
explanation for our findings might be that people with
AMD were less physically active than controls when ob-
jectively measured and less physically active individuals
are known to report their MVPA with less bias [16]. Al-
though clinicians may use self-report to monitor the
compliance of AMD subjects with any prescribed exer-
cise programs, they should be aware that a valid com-
parison with healthy controls can only be made when
MVPA is objectively measured.
The agreement between self-reported and objectively
measured sedentary behaviour was poor and not signifi-
cantly different between groups. Compared to the
objective measure, sedentary time was on average under-
reported 170 min/day which is less than found previ-
ously in a sample of British adults (349min/day) [16].
The difference in under-reporting between the two stud-
ies is likely because a more physically active sample of
the British population was included in the present study
[16].
Compared to controls, AMD subjects with and with-
out vision loss engaged 71–73 min/day less time in
Fig. 2 Agreement between the objective (i.e., Actigraph accelerometer) and subjective (i.e., global physical activity questionnaire [GPAQ]) physical
activity measure. The panels show the Bland-Altman plots for sedentary behaviour per group (panels a, b, c), difference in agreement between
groups (mean ± SD) for sedentary behaviour (d), Bland-Altman plots for moderate-to-vigorous physical activity (MVPA) per group (panels e, f, g),
and the difference in agreement between groups (mean ± SD) for MVPA (h). The round symbols represent individual scores. In Figs. A, B, C, E, F,
and G: the solid horizontal line represents the mean difference between the objective and subjective physical activity score (i.e., bias) and the
dashed horizontal lines represent the 95% limits of agreement. *, borderline significant difference between groups (p≤ 0.058)
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MVPA when objectively measured, but between-group
differences were absent with self-reported MVPA data.
Previous accelerometer-based research showed that indi-
viduals with vision loss were more sedentary and less
active in both light-intensity and MVPA [11]. However,
and in contrast to the findings of the present study,
physical activity levels in AMD subjects with good bin-
ocular vision were not significantly different from
healthy controls [11]. It is hard to compare their findings
with ours because they used different criteria to measure
light-intensity activity (100–2019 cpm vs. 100–1040
cpm) and MVPA (≥ 2020 cpm vs. ≥ 1041 cpm). The
Table 3 Pearson’s correlations (r) between physical activity measures and vision loss parameters across all subjects (n = 32)
Visual acuity (logMAR) Contrast sensitivity (logCS) Visual fields (dB)
R p-value R p-value r p-value
Actigraph
Sedentary behaviour (min/day) 0.324 0.035 −0.384 0.015 −0.413 0.009
Light-intensity activity (min/day) −0.335 0.030 0.290 0.054 0.150 0.206
MVPA (min/day) −0.384 0.015 0.443 0.006 0.341 0.028
Step count (steps/day) −0.129 0.240 0.162 0.188 0.028 0.439
GPAQ
Sedentary behaviour (min/day) −0.303 0.046 0.114 0.266 −0.043 0.407
MPVA (min/day) 0.059 0.373 −0.004 0.491 0.055 0.383
GPAQ, Global Physical Activity Questionnaire; MVPA, moderate-to-vigorous physical activity
Fig. 3 Pearson’s correlations between visual acuity and objective physical activity measures across all subjects. The panels show the correlations
for sedentary behaviour (a), light-intensity activity (b), moderate-to-vigorous physical activity (MVPA) (c), and step count (d). The round symbols
represent individual scores
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criteria in the present study were chosen because they
are specifically developed for older adults [29]. Although
our people with AMD spent less time in MVPA com-
pared to controls, they met the physical activity guide-
lines of being moderately active for at least 150 min per
week [37].
The number of steps per day was not different for
AMD subjects with and without good binocular vision
compared to healthy controls. However, AMD subjects
with and without good binocular vision did not achieve
the recommended 7000–10,000 steps/day [38] in con-
trast to the healthy controls who walked 8258 steps/day.
Walking is the primary form of MVPA in older adults
but older adults with AMD seem to engage less in other
types of MVPA (see Fig. 1). The reasons that older
adults with AMD engage less in other physical activities
are likely related to the environment (e.g., transportation
difficulties, lack of accessible exercise equipment) and to
the societal attitude towards people with vision loss [2].
There was a weak to moderate relationship between
the severity of vision loss and any of the objectively mea-
sured physical activity levels. These findings support pre-
vious research where a loss in visual acuity, contrast
sensitivity, and visual field were all associated with less
engagement in MVPA [11, 39]. The present study is the
first to show that vision loss is associated with less en-
gagement in light-intensity activities and more sedentary
behaviour. Interestingly, correlations between vision loss
and self-reported physical activity levels were less strong
and in the opposite direction than when physical activity
levels were objectively measured. Objective instead of
self-report measures of physical activity should be used
in future research to accurately quantify associations be-
tween vision loss and physical activity.
Limitations of hip-worn accelerometers are that they
cannot be worn during water-based activities and that
they underestimate the activity count of lower limb
movements (e.g., cycling). Ten of our participants used a
bicycle for transportation (1 AMD subjects with vision
loss, 4 AMD subjects without vision loss, 5 controls) and
seven subjects participated in swimming (2 AMD sub-
jects with vision loss, 3 AMD subjects without vision
loss, 2 controls) so it is likely that our objectively
measured physical activity levels are underestimated.
Therefore, the discrepancy between self-reported and
accelerometer-based MVPA might have been more than
presented in each group.
The difference in measurement timeframe between ad-
ministering the GPAQ and the accelerometer might also
have affected the results. The GPAQ is developed to
measure physical activity during “a typical week” and
was administered before subjects started to wear the ac-
celerometer. The accelerometer was worn during “a typ-
ical week” but wearing an accelerometer and using a log
might have resulted in subjects becoming more physic-
ally active than usual (i.e., Hawthorne effect). Had the
GPAQ been administered after the subjects completed
the wearing of the accelerometer, GPAQ responses
might have been a better reflection of “a typical week” in
which the accelerometer was worn. The effect of admin-
istration time on self-reported physical activity will be
similar across groups and will therefore not affect the
conclusions of the present study.
Conclusions
In this study, all the subjects under-reported their seden-
tary behaviour and MVPA. The agreement between self-
reported and objectively measured MVPA was better in
AMD subjects with and without vision loss than con-
trols. Thus, in contrast to our hypothesis, individuals
with AMD did not have a tendency to self-report socially
desirable behaviour. However, people with AMD,
Fig. 4 Pearson’s correlations between visual acuity and subjective physical activity measures across all subjects. The panels show the correlations
for sedentary behaviour (a) and moderate-to-vigorous physical activity (MVPA) (b). The round symbols represent individual scores
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irrespective of whether they were vision impaired, en-
gaged less in MVPA than controls when objectively
measured and these between-group differences would
have remained unnoticed had MVPA only been mea-
sured subjectively. Clinicians may use self-reported phys-
ical activity levels to monitor the compliance of AMD
subjects with prescribed exercise programs but they
should be aware that a valid comparison with healthy
controls can only be made when MVPA is objectively
measured.
Abbreviations
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